Hernia disease and collagen gene regulation: Are there clues for intervention?

Hernia

Volumn 10, Issue 6, 2006, Pages 486-491

  Lynen Jansen, Petra ^a   Klinge, Uwe ^a   Mertens, Peter R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Collagen expression; Gene regulation; Synthesis; Transcription

Indexed keywords

ALPHA INTERFERON; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 11; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 9; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OLIGODEOXYNUCLEOTIDE; SMAD3 PROTEIN; SMAD4 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; Y BOX BINDING PROTEIN 1;

AMINO ACID SUBSTITUTION; ASCORBIC ACID DEFICIENCY; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONGESTIVE HEART FAILURE; DRUG TARGETING; ENVIRONMENTAL FACTOR; GENE CONTROL; GENE EXPRESSION REGULATION; GENE MUTATION; GENE TARGETING; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HERNIA; HUMAN; METABOLIC SYNDROME X; NONHUMAN; NONVIRAL GENE THERAPY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; REGULATORY SEQUENCE; REVIEW; RNA INTERFERENCE; SCAR FORMATION; SIGNAL TRANSDUCTION; SMOKING; TENSILE STRENGTH; TRANSCRIPTION REGULATION;

ANIMALS; COLLAGEN; DNA; GENE EXPRESSION REGULATION; HERNIA; HUMANS; WOUND HEALING;

EID: 33751531095     PISSN: 12654906     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10029-006-0147-6     Document Type: Review

References (31)

1. Junge K, Klinge U, Rosch R, Mertens PR, Kirch J, Klosterhalfen B, Lynen P, Schumpelick V (2004) Decreased collagen type I/III ratio in patients with recurring hernia after implantation of alloplastic prostheses. Langenbecks Arch Surg 389:17-22
2. Klinge U, Si ZY, Zheng H, Schumpelick V, Bhardwaj RS, Klosterhalfen B (2000) Abnormal collagen I to III distribution in the skin of patients with incisional hernia. Eur Surg Res 32:43-48
3. Taniguchi S, Ueda K, Inoue T, Li TS, Kuga T, Hamano K (2006) Impact of collagen subtype proportions in peritoneal tissues on inguinal hernia formation in adults and infants. Pediatr Surg Int 22:600-604
4. Hunt TK, Goodson WH (1988) Wound healing. Br J Surg 75:188-189
5. Silver FH, Christiansen DL, Snowhill PB, Chen Y (2000) Role of storage on changes in the mechanical properties of tendon and self-assembled collagen fibers. Connect Tissue Res 41:155-164
6. Linsenmayer TF, Fitch JM, Birk DE (1990) Heterotypic collagen fibrils and stabilizing collagens. Controlling elements in corneal morphogenesis? Ann NY Acad Sci 580:143-160
7. Ninomiya Y, Olsen BR (1984) Synthesis and characterization of cDNA encoding a cartilage-specific short collagen. Proc Natl Acad Sci USA 81:3014-3018
8. Kuivaniemi H, Tromp G, Prockop DJ (1997) Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum Mutat 9:300-315
9. Menashi S, Campa JS, Greenhalgh RM, Powell JT (1987) Collagen in abdominal aortic aneurysm: Typing, content, and degradation. J Vasc Surg 6:578-582
10. Lehnert B, Wadouh F (1992) High coincidence of inguinal hernias and abdominal aortic aneurysms. Ann Vasc Surg 6:134-137
11. Mautner J, Behrends U, Hortnagel K, Brielmeier M, Hammerschmidt W, Strobl L, Bornkamm GW, Polack A (1996) c-myc expression is activated by the immunoglobulin kappa-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo. Oncogene 12:1299-1307
12. Yamada Y, Ando F, Niino N, Shimokata H (2005) Association of a -1997G->T polymorphism of the collagen Ialpha1 gene with bone mineral density in postmenopausal Japanese women. Hum Biol 77:27-36
13. Si Z, Bhardwaj R, Rosch R, Mertens PR, Klosterhalfen B, Klinge U, Rhanjit B, Rene PM (2002) Impaired balance of type I and type III procollagen mRNA in cultured fibroblasts of patients with incisional hernia. Surgery 131:324-331
14. Mertens PR, Harendza S, Pollock AS, Lovett DH (1997) Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2átranscription is mediated by YB-1. J Biol Chem 272:22905-22912
15. Mertens PR, Steinmann K, Alfonso-Jaume MA, En-Nia A, Sun Y, Lovett DH (2002) Combinatorial interactions of p53, AP2 and YB-1 with a single enhancer element regulate gelatinase a expression in neoplastic cells. J Biol Chem 277: 24875-24882
16. Cutroneo KR (2003) How is type I procollagen synthesis regulated at the gene level during tissue fibrosis. J Cell Biochem 90:1-5
17. Tan FK (2006) Autoantibodies against PDGF receptor in scleroderma. N Engl J Med 354:2709-2711
18. Overall CM, Lopez-Otin C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657-672
19. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T (2003) Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem 253:269-285
20. Kleiner DE Jr, Stetler-Stevenson WG (1993) Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol 5:891-897
21. Harendza S, Pollock AS, Mertens PR, Lovett DH (1995) Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J Biol Chem 270:18786-18796
22. Marti HP, McNeil L, Davies M, Martin J, Lovett DH (1993) Homology cloning of rat 72 kDa type IV collagenase: Cytokine and second-messenger inducibility in glomerular mesangial cells. Biochem J 291:441-446
23. Overall CM, Wrana JL, Sodek J (1989) Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 264:1860-1869
24. Norman JT, Lindahl GE, Shakib K, En-Nia A, Yilmaz E, Mertens PR (2001) The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter. J Biol Chem 276:29880-29890
25. Peltonen L, Halila R, Ryhanen L (1985) Enzymes converting procollagens to collagens. J Cell Biochem 28:15-21
26. Kirsch E, Ihme A, Muller P, Krieg T (1982) Molecular defects in inborn disorders of collagen metabolism. Enzyme 27:239-258
27. Matskevichus ZK (1987) Mechanisms and role of collagen biodegradation in pathology. Arkh Patol 49:3-10
28. Vogel S, Volk HW, Wasmer HP, Buchwald J (1991) Treatment of iatrogenic esophageal perforation. Zentralbl Chir 116:751-756
29. Yin L, Morita A, Tsuji T (2000) Alterations of extracellular matrix induced by tobacco smoke extract. Arch Dermatol Res 292:188-194
30. Jesmin S, Sakuma I, Hattori Y, Kitabatake A (2003) Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats. Arterioscler Thromb Vasc Biol 23:2021-2026
31. Prockop DJ, Kadler KE, Hojima Y, Constantinou CD, Dombrowski KE, Kuivaniemi H, Tromp G, Vogel B (1988) Expression of type I procollagen genes. Ciba Found Symp 136:142-160